Q
Quant'AbondanceL'abondance, quantifiée.

Actualités

Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.

25,544 signal articles · 29 in last 24h · 122,414 total before filter · latest 2h ago
29last 24h
1242last 7d
206● bullish (7d)
149● bearish (7d)
205publishers
AllMacro209Earnings424M&A97Regulatory24Product8Analyst10
✕ clear all filterssentiment: bullishSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
The Bull Case For Novanta (NOVT) Could Change Following An Earnings-Driven Analyst Upgrade - Learn Why
Simply Wall St.57d agobullish
The Bull Case For Novanta (NOVT) Could Change Following An Earnings-Driven Analyst Upgrade - Learn Why

Novanta was recently upgraded to a Zacks Rank #2 (Buy), reflecting increased analyst optimism tied to an upward revision in earnings estimates. This earnings-driven upgrade highlights how changing expectations about Novanta's profit outlook can influence investor attention and perceived business strength over time. Next, we'll examine how the upgraded earnings outlook and analyst ranking could reshape Novanta's existing investment narrative and risk profile. Invest in the nuclear...

SpaceX Joins Nasdaq-100 on July 7. Its Stock is Still Not a Buy
24/7 Wall St.57d agobullish
SpaceX Joins Nasdaq-100 on July 7. Its Stock is Still Not a Buy

The biggest IPO in history is about to reach another milestone, but smart investors shouldn’t confuse forced buying with lasting value. On July 7, SpaceX (NASDAQ:SPCX) will officially join the Nasdaq-100 after the Nasdaq exchange rewrote its eligibility rules to allow newly public mega-cap companies into the index without waiting through the traditional seasoning period. ... SpaceX Joins Nasdaq-100 on July 7. Its Stock is Still Not a Buy

Eli Lilly (LLY) Wins EMA Backing For Jaypirca In Chronic Lymphocytic Leukemia
Simply Wall St.57d agobullish
Eli Lilly (LLY) Wins EMA Backing For Jaypirca In Chronic Lymphocytic Leukemia

Eli Lilly's cancer drug Jaypirca received a positive opinion from the European Medicines Agency regarding its use in chronic lymphocytic leukemia. The opinion supports potential use of Jaypirca across all lines of therapy for CLL in Europe. The recommendation is based on Phase 3 clinical trial data and now moves to European Commission review. Eli Lilly (NYSE:LLY) is best known recently for its GLP-1 portfolio, and oncology remains an important part of the business. The EMA's positive view...

The SpaceX $17 billion spectrum buy finally makes sense
TheStreet57d agobullish
The SpaceX $17 billion spectrum buy finally makes sense

SpaceX spent close to two years and nearly $20 billion buying wireless spectrum licenses that had nothing to do with rockets or satellite broadband. Analysts struggled to explain why a space company needed land-based mobile spectrum at all. That question now has an answer, and it puts the country’s ...

Eli Lilly Leads 5 Stocks Near Buy Points As The Market Rally Rotates
Investor's Business Daily57d agobullish
Eli Lilly Leads 5 Stocks Near Buy Points As The Market Rally Rotates

Eli Lilly and EZ Corp. lead stocks to watch near buy points this week as investors seek shelter in defensive growth names. The relative strength lines of all top five stocks near buy points are making new highs or near highs. The strong RS lines, which track performance vs. the S&P 500, are especially bullish given the overall uncertain stock market.

The Insane Number HPE’s CEO Just Threw Out Shows Why Bloom Energy Is a Buy Today
24/7 Wall St.57d agobullish
The Insane Number HPE’s CEO Just Threw Out Shows Why Bloom Energy Is a Buy Today

The artificial intelligence boom has shifted from a race for chips to a race for electricity. Every new AI data center requires enormous amounts of reliable power, yet the U.S. electric grid is struggling to keep pace. That mismatch is becoming one of the defining investment themes of the decade. While semiconductor companies remain at ... The Insane Number HPE’s CEO Just Threw Out Shows Why Bloom Energy Is a Buy Today

Is Hudbay Minerals (HBM) One of the High Growth Stocks to Buy Right Now?
Insider Monkey57d agobullish
Is Hudbay Minerals (HBM) One of the High Growth Stocks to Buy Right Now?

Hudbay Minerals Inc. (NYSE:HBM) is one of the high growth stocks to buy right now. On June 17, Hudbay Minerals announced the pricing of $52 million in 4.50% municipal bonds to support its Copper World project in Pima County, Arizona. Issued by the Arizona Industrial Development Authority, the proceeds will be used to finance, reimburse, […]

Nextpower (NXT) Buys Zimmermann To Grow Its European Solar Business
Simply Wall St.57d agobullish
Nextpower (NXT) Buys Zimmermann To Grow Its European Solar Business

Nextpower (NasdaqGS:NXT) has agreed to acquire Zimmermann PV-Steel Group to widen its presence in the European solar market. The deal is structured as a definitive agreement and is expected to close in the second half of fiscal 2027, subject to regulatory approvals. Zimmermann PV-Steel Group will operate as a Nextpower company, using Nextpower's global infrastructure to distribute its products. For investors watching the solar supply chain, the planned acquisition of Zimmermann PV-Steel...

Costco reveals why Kirkland keeps beating name brands
TheStreet57d agobullish
Costco reveals why Kirkland keeps beating name brands

For many shoppers, a trip to Costco starts with a simple question. "Is there a Kirkland version?" Over the past three decades, the warehouse club giant has transformed Kirkland Signature from a low-cost private label into one of retail's most trusted brands. Today, shoppers often choose ...

Bank Of America (BAC) Sees Younger Homebuyers Return As It Expands World Cup Programs
Simply Wall St.57d agobullish
Bank Of America (BAC) Sees Younger Homebuyers Return As It Expands World Cup Programs

Bank of America (NYSE:BAC) reports a new homebuyer survey indicating rising buyer intent despite high mortgage rates, especially among Gen Z and Millennial respondents. The company is increasing its role in community programs as the Official Bank of FIFA World Cup 2026™, including support for the Street Child United #IAmSomebody Tour. For readers watching the U.S. housing market, Bank of America sits at the intersection of consumer sentiment and mortgage activity. The latest survey suggests...

Bloomberg57d agobullish
Apple Seeks US Approval to Buy Chips From Blacklisted CXMT: FT

(Bloomberg) -- Apple Inc. is pressing the White House for approval to purchase memory chips from a blacklisted Chinese company as it grapples to rein in chip costs, the Financial Times reported on Saturday.Most Read from BloombergLutnick Delayed Canada Bridge Debut to Seek Bigger Cut of Toll RevenueIndonesia Opens Door to Dirty Money to Fund Prabowo’s PlansOman Tells Allies Ships Going Through Hormuz May Have to PayApple Shares Sink After Price Hikes Hit iPads and MacsUS Strikes Iran in Response

Tutor Perini (TPC) Stock After 70% One-Year Surge Is The Rally Getting Stretched
Simply Wall St.57d agobullish
Tutor Perini (TPC) Stock After 70% One-Year Surge Is The Rally Getting Stretched

If you are wondering whether Tutor Perini at around US$79.53 still offers value after its strong run, this article walks through how the current price stacks up against several valuation checks. The stock has logged returns of 2.0% over the past week, 6.8% over the past month, 14.7% year to date and 70.2% over the last year, with a very large gain over three years that is more than 10 times and 486.7% over five years. This naturally raises questions about what is already priced in. Recent...

Analog Devices (ADI) Buys Empower As Record Revenue Deepens Its AI Push
Simply Wall St.57d agobullish
Analog Devices (ADI) Buys Empower As Record Revenue Deepens Its AI Push

Analog Devices reported record revenue, supported by demand from AI data centers and industrial customers. The company announced an agreement to acquire Empower Semiconductor to expand its AI power management capabilities. The stock, NasdaqGS:ADI, last closed at $386.91 as investors assess the earnings update and acquisition news. Analog Devices enters this news cycle with a share price of $386.91 and long term returns that include 41.3% year to date, 65.5% over 1 year, 108.5% over 3 years,...